Dr Tanja Potpara (Belgrade University School of Medicine, Belgrade, Serbia) kindly discussed with us her presentation on the journey of patients on novel oral anticoagulants (NOACs), which was presented during a session on atrial fibrillation clinical cases with focus on rhythm control and anticoagulation at this years EHRA.
‘NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication‘ was presented at EHRA 2022, 03-05 April, 2022.
Questions
- What did your presentation raise regarding the management of patients with atrial fibrillation after acute coronary syndrome and/or percutaneous coronary intervention? (0:21)
- What issues were raised in terms of dosage in renal dysfunction and the concurrent use of other medications? (7:07)
- What were the key take-home messages of the presentation? (9:05)
Disclosures: Tatjana Potpara has nothing to disclose in relation to this video
Support:Â Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the annual EHRA Conference 2022.
